News

RXi and EyeGate have announced a collaboration focused on non-invasive ocular delivery of RNAi therapeutics. Both companies will contribute technology, expertise and resources to the partnership.

Researchers have found that giving patients a dual therapy of bimatoprost and a beta-blocker is an effective method of lowering intraocular blood pressure (IOP) in patients with open-angle glaucoma.

The Pediatric Cataract Initiative has set a deadline of 15 November for the receipt of applications for its inaugural single small research grant.

Allergan has been given FDA approval for its drug Ozurdex (dexamethasone intravitreal implant) 0.7 mg for the treatment of non-infectious ocular inflammation.

ISTA Pharmaceuticals has highlighted results from its Phase 2 clinical study on Remura dry eye solution.

ISTA Pharmaceuticals has highlighted results from its Phase 2 clinical study on Remura dry eye solution.

Experience the material-friendly way of marking.

Acucela and Otsuka Pharmaceutical have entered into a definitive agreement for the joint development and promotion of OPA-656, an adenosine A2a receptor agonist under development for treating glaucoma.

Transitions Optical and the US National Council of Negro Women (NCNW) are collaborating to raise awareness about the importance of proper vision care and vision wear among the Africa-American community.

Investigators from The Scripps Research Institute, and Thomas Reh, PhD from the University of Washington, received the highest possible scores for their proposal to investigate the regenerative potential of retinal cells, resulting in a $4.66 million NIH Transformative Award.

AstraZeneca and UCL Institute of Ophthalmology are collaborating to develop regenerative medicines for diabetic retinopathy (DR).

opcon has launched the LENTIS Mplustoric intraocular lens (IOL.

Applied Genetics Technology Corporation (AGTC) has received a grant from the FDA (FDA Orphan Drugs Programme) to fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease.

A clinical trial is being conducted by the Cornea and Laser Eye Institute (CLEI) into the efficacy and safety of corneal collagen crosslinking (CXL) using riboflavin/dextran and hypotonic riboflavin in patients with progressive keratoconus and corneal ectasia.

OTEurope reports on some of the highlights from the XXVIII Congress of the European Society of Cataract and Refractive Surgeons.

Doctors may be the first clinicians to detect the presence of a sexually transmitted disease (STD) when discovering ocular manifestations associated with STDs. However, since many of the ocular manifestations of STDs can be present with other conditions, further work is required.

A new multifocal IOL optic has been designed to overcome glare, halos, night vision difficulties and loss of contrast sensitivity present in current multifocal products.

OTEurope reports on some of the highlights from the XXVIII Congress of the European Society of Cataract and Refractive Surgeons.

Dr Michael Trese explains how a web-based disease management imaging system could enhance screening for retinopathy of prematurity through acquisition and reading of weekly digital retinal images, hospital support and more opportunities for parental involvement.

OTEurope reports on some of the highlights from the XXVIII Congress of the European Society of Cataract and Refractive Surgeons.

New findings from the ongoing African Descent and Glaucoma Evaluation Study (ADAGES) support previous results indicating that ancestry differences in visual function in healthy eyes are likely to be a sign of early disease.

Collaborative research has led to the development of an adaptive optics-optical coherence tomography (AO-OCT) system that allows ophthalmologists to see the eye's retina at the individual level.

Ophthalmic blogger, Irv Arons writes a tell all on what stem cells are all about, who's involved, who they are collaborating with, what type of stem cells they are using and what diseases they are aimed at.

OTEurope reports on some of the highlights from the XXVIII Congress of the European Society of Cataract and Refractive Surgeons.

OTEurope reports on some of the highlights from the XXVIII Congress of the European Society of Cataract and Refractive Surgeons.

OTEurope reports on some of the highlights from the XXVIII Congress of the European Society of Cataract and Refractive Surgeons.

We report on a new excimer treatment for presbyopia.

OTEurope reports on some of the highlights from the XXVIII Congress of the European Society of Cataract and Refractive Surgeons.

A glaucoma specialist outlines the seven deadly sins of glaucoma management that, if avoided, can greatly reduce the number of people who go blind from glaucoma. These points include making sure that diagnosis occurs promptly and that patient compliance is stressed.

Although near vision can never be assessed objectively, standardization between tests would be useful. However, there is a lack of standardization between tests so that comparison of results of different near vision tests is difficult, or not possible. Dr Oliver Findl explains.